DUANE BOISE MMJ TEAM-DEA DELAYS CLINICAL TRIALS IN MS & HUNTINGTON'S DISEASE-
MMJ companies is building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in Multiple Sclerosis and Huntington's Disease. MMJ was awarded the much coveted Orphan Designation from the FDA for its planned Huntington's Disease trials. MMJ has also received a DEA schedule 1 analytical cannabis lab license but the company is still awaiting the final DEA award to cultivate its strain specific marijuana as a pharmaceutical to supply these clinical trials.
MMJ companies is building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in Multiple Sclerosis and Huntington's Disease. MMJ was awarded the much coveted Orphan Designation from the FDA for its planned Huntington's Disease trials. MMJ has also received a DEA schedule 1 analytical cannabis lab license but the company is still awaiting the final DEA award to cultivate its strain specific marijuana as a pharmaceutical to supply these clinical trials.
Category
🗞
News